Cardiovascular disease (CVD) is the leading cause of death globally, with more than four out of five CVD deaths due to heart attacks and strokes. One-third of these deaths occur prematurely in people under 70 years of age.
That’s why our work in this area is so critical. We want to find out who is at risk of developing blocked arteries which will allow us to predict heart attack and stroke, and develop new treatments. We’re also conducting trials of anti-inflammatory, anti-diabetic and lipid-lowering drugs in people who have experienced a heart attack with the aim of reducing damage to the heart and preventing further heart attacks.
